热门资讯> 正文

Autolus Therapeutics 2026年第二季度盈利预览

2026-08-10 23:00

Autolus Therapeutics(AUTL) 0

Autolus Therapeutics (AUTL) is scheduled to announce Q2 earnings results on Tuesday, August 11th, before market open.
The consensus EPS Estimate is -$0.19 (-5.6% Y/Y) and the consensus Revenue Estimate is $40.15M (+92.1% Y/Y).
Over the last 1 year, AUTL has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 6 upward revisions and 0 downward. Revenue estimates have seen 5 upward revisions and 0 downward.

More on Autolus Therapeutics

Autolus Therapeutics: Navigating A Bumpy 2026
Autolus Therapeutics plc (AUTL) Q1 2026 Earnings Call Transcript
Autolus Therapeutics plc 2026 Q1 - Results - Earnings Call Presentation
Autolus reiterates $120M-$135M 2026 AUCATZYL revenue guidance as it targets 65%-70% peak ALL gross margin
Autolus Therapeutics Q1 2026 Earnings Preview

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。